You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Latent Tuberculosis

Showing 76 - 100 of 1,604
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Tuberculosis Trial (Isoniazid and Rifapentine (INH-RPT), Placebo)

Not yet recruiting
  • Diabetes Mellitus
  • Tuberculosis
  • Isoniazid and Rifapentine (INH-RPT)
  • Placebo
  • (no location specified)
Oct 19, 2020

HIV, Tuberculosis Trial in United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • San Francisco, California
  • +24 more
Oct 26, 2021

Chronic Liver Disease, TB Trial in Pittsburgh (collection of blood sample)

Withdrawn
  • Chronic Liver Disease
  • TB
  • collection of blood sample
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
May 5, 2020

Tuberculosis Infection Trial in Terrassa (TB infection-screening benefiting group)

Unknown status
  • Tuberculosis Infection
  • TB infection-screening benefiting group
  • Terrassa, Barcelona, Spain
    Hospital Universitari Mutua Terrassa
Jul 17, 2020

Enhanced Tuberculosis Infection Control Intervention in

Completed
  • Tuberculosis
  • Enhanced TB IC Package
  • Maruphong, Cha Cherng Sao, Thailand
  • +21 more
Feb 1, 2021

Latent Tuberculosis Infection Trial in Worldwide (Latent Tuberculosis Infection program evaluation & diagnosis)

Completed
  • Latent Tuberculosis Infection
  • Latent Tuberculosis Infection program evaluation & diagnosis
  • Cotonou, Benin
  • +7 more
Feb 20, 2020

Determining Risk in Latent Tuberculosis

Terminated
  • Latent Tuberculosis
    • Seoul, Korea, Republic of
      National Medical Center
    Nov 22, 2019

    Latent Tuberculosis Bacteriology and Histology Unknown, Latent Tuberculosis Trial in Khayelitsha, Worcester (H56ug/IC31nmol,

    Completed
    Has Results
    • Latent Tuberculosis Bacteriology and Histology Unknown
    • Latent Tuberculosis
    • H56ug/IC31nmol
    • Placebo
    • Khayelitsha, Cape Town, South Africa
    • +1 more
    Dec 3, 2019

    HIV, Tuberculosis Infection, Hepatitis C Trial (ART Therapy)

    Active, not recruiting
    • HIV Infections
    • +3 more
    • ART Therapy
    • (no location specified)
    Dec 16, 2020

    Tuberculosis Trial in Badalona, Esplugues de Llobregat, Barcelona (Nyaditum resae ® 10e5 of heat-killed Mycobacterium

    Completed
    • Tuberculosis
    • Nyaditum resae ® 10e5 of heat-killed Mycobacterium manresensis
    • Placebo
    • Badalona, Barcelona, Spain
    • +2 more
    Dec 3, 2019

    Tuberculosis, Tuberculosis Infection Trial in Lyon (Multiple blood samples, Single blood sample)

    Recruiting
    • Tuberculosis
    • Tuberculosis Infection
    • Multiple blood samples
    • Single blood sample
    • Lyon, France
      Service des Maladies Infectieuses - Hôpital de la Croix Rousse -
    Feb 12, 2020

    Tuberculosis Trial in San Francisco (Isoniazid, Rifampin)

    Completed
    Has Results
    • Tuberculosis
    • San Francisco, California
      University of California San Francisco
    Jul 13, 2020

    Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))

    Completed
    Has Results
    • Tuberculosis
    • HIV Infections
    • Rifapentine (RPT)
    • +2 more
    • La Jolla, California
    • +44 more
    Nov 2, 2021

    Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis

    Unknown status
    • Tuberculosis Infection
    • TB-antigen responsive T cell markers
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 31, 2019

    Latent Tuberculosis, Latent Tuberculosis Bacteriology and Histology Unknown Trial in Worcester (H56:IC31)

    Completed
    Has Results
    • Latent Tuberculosis
    • Latent Tuberculosis Bacteriology and Histology Unknown
    • H56:IC31
    • Worcester, South Africa
      SATVI Project Office, Brewelskloof Hospital
    Aug 20, 2019

    /or Prognostic Markers of IRIS in TB-HIV Co-infected Patients

    Unknown status
    • HIV Infection
    • Tuberculosis Infection
    • Detection of molecular Biomarkers
    • Phnom Penh, Cambodia
      Institut Pasteur du Cambodge
    Jan 6, 2020

    HIV, Tuberculosis Trial in Puerto Rico, United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

    Completed
    • HIV Infections
    • Tuberculosis
    • Birmingham, Alabama
    • +75 more
    Oct 26, 2021

    Tuberculosis Trial in Oxford, Birmingham, London (Aerosol inhaled MVA85A, Intramuscular MVA85A, Intramuscular Saline )

    Terminated
    Has Results
    • Tuberculosis
    • Aerosol inhaled MVA85A
    • +3 more
    • Oxford, Oxfordshire, United Kingdom
    • +4 more
    Aug 14, 2020

    Tuberculosis, Pulmonary Trial in Godoy Cruz (RUTI® Vaccine, Placebo)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • RUTI® Vaccine
    • Placebo
    • Godoy Cruz, Mendoza, Argentina
      Hospital José Nestor Lencinas
    Jul 26, 2022

    Kidney Transplant Infection, Tuberculosis, Isoniazid Toxicity Trial (Isoniazid, without any additional anti-tuberculosis

    Not yet recruiting
    • Kidney Transplant Infection
    • +2 more
    • Isoniazid
    • without any additional anti-tuberculosis treatment
    • (no location specified)
    Mar 21, 2022

    Video Based Directly Observed Therapy for Latent TB

    Withdrawn
    • Latent Tuberculosis
    • Rifapentine 600 mg orally
    • +2 more
    • Saint Louis, Missouri
      Saint Louis University
    Jun 27, 2019

    Latent Tuberculosis, HIV Trial in Klerksdorp, Potchefstroom (QGIT)

    Completed
    • Latent Tuberculosis
    • HIV
    • QGIT
    • Klerksdorp, North West, South Africa
    • +13 more
    Oct 2, 2019

    Blood Transcriptomic Signatures for Diagnosis of Active

    Recruiting
    • TUBERCULOSIS, PULMONARY
    • ISIT-TB prototype
    • Cape Town, South Africa
      University of Cape Town Lung Institute
    Jan 25, 2022

    Tuberculosis Trial in Lambaréné (VOT with and without cash incentive)

    Completed
    • Tuberculosis
    • VOT with and without cash incentive
    • Lambaréné, Gabon
      Centre de recherches médicales de Lambaréné
    May 9, 2023

    Tuberculosis Trial in Ottawa (3HP)

    Completed
    • Tuberculosis
    • Ottawa, Ontario, Canada
      The Ottawa Hospital - General Campus
    Mar 20, 2020